Melanoma and Immune Checkpoint Inhibitors

被引：0
|
作者：
Masutaka Furue
Takamichi Ito
Naoko Wada
Maiko Wada
Takafumi Kadono
Hiroshi Uchi
机构：
[1] Kyushu University,Department of Dermatology
[2] St. Marianna University School of Medicine,Department of Dermatology
来源：
Current Oncology Reports | 2018年 / 20卷
关键词：
Melanoma; Immune checkpoint inhibitors; Ipilimumab; Nivolumab; Pembrolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors
    Olbryt, Magdalena
    Rajczykowski, Marcin
    Widlak, Wieslawa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 1 - 20
  • [42] Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma
    Emanuelle M. Rizk
    Angelina M. Seffens
    Megan H. Trager
    Michael R. Moore
    Larisa J. Geskin
    Robyn D. Gartrell-Corrado
    Winston Wong
    Yvonne M. Saenger
    American Journal of Clinical Dermatology, 2020, 21 : 1 - 11
  • [43] Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors.
    Shao, Yusra F.
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    In, Gino Kim
    Hoon, Dave S. B.
    Domingo-Musibay, Evidio
    Darabi, Sourat
    Eisenberg, Burton Larry
    Sato, Takami
    Gibney, Geoffrey Thomas
    Mamdani, Hirva
    Moser, Justin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma
    Rosner, Samuel
    Agrawal, Yuri
    Sun, Daniel Q.
    Aygun, Nafi
    Schollenberger, Megan D.
    Lipson, Evan
    Naidoo, Jarushka
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [45] Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma
    Takemoto, Keita
    Makino, Teruhiko
    Kagoyama, Ko
    Furukawa, Fumina
    Mizawa, Megumi
    Shimizu, Tadamichi
    JOURNAL OF DERMATOLOGY, 2023, 50 (09): : E292 - E294
  • [46] Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma
    Sada, Ikuyo
    Harada, Yosuke
    Hiyama, Tomona
    Mizukami, Mina
    Kan, Takanobu
    Kawai, Mikio
    Kiuchi, Yoshiaki
    MELANOMA RESEARCH, 2023, 33 (06) : 539 - 546
  • [47] Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases
    Tyler P. Robin
    Robert E. Breeze
    Derek E. Smith
    Chad G. Rusthoven
    Karl D. Lewis
    Rene Gonzalez
    Amanda Brill
    Robin Saiki
    Kelly Stuhr
    Laurie E. Gaspar
    Sana D. Karam
    David Raben
    Brian D. Kavanagh
    Sameer K. Nath
    Arthur K. Liu
    Journal of Neuro-Oncology, 2018, 140 : 55 - 62
  • [48] Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
    Wong, Selina K.
    Blum, Steven M.
    Sun, Xiaopeng
    Silva, Ines P. Da
    Zubiri, Leyre
    Ye, Fei
    Bai, Kun
    Zhang, Kevin
    Ugurel, Selma
    Zimmer, Lisa
    Livingstone, Elisabeth
    Schadendorf, Dirk
    Serra-Bellver, Patricio
    Munoz-Couselo, Eva
    Ortiz, Carolina
    Lostes, Julia
    Huertas, Roberto M.
    Arance, Ana
    Pickering, Lisa
    V. Long, Georgina
    Carlino, Matteo S.
    Buchbinder, Elizabeth I.
    Vazquez-Cortes, Leticia
    Jara-Casas, Diego
    Marquez-Rodas, Ivan
    Gonzalez-Espinoza, Ivan R.
    Balko, Justin M.
    Menzies, Alexander M.
    Sullivan, Ryan J.
    Johnson, Douglas B.
    EUROPEAN JOURNAL OF CANCER, 2023, 181 : 188 - 197
  • [49] Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma
    Tarhini, Ahmad A.
    Joshi, Ila
    Garner, Fiona
    IMMUNOTHERAPY, 2021, 13 (12) : 1011 - 1029
  • [50] Posterior cord syndrome associated with immune checkpoint inhibitors for metastatic melanoma
    Secco, L. -p.
    Lesage, C.
    Lippi, A.
    Maria, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (03): : 193 - 194
12345